glp 1 is retatrutide Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Retatrutide for weight loss: Study

Cardiovascular and Metabolic Health

Acknowledgements and funding The authors work on gut-derived hormones and obesity-diabetes has been generously supported over many years by Diabetes UK, Invest Northern Ireland, the Irish Endocrine Society, Northern Ireland Department for the Economy, and Ulster University Strategic Funding

Emphasizing the medical necessity of these drugs for patients with diabetes can help reframe the public narrative

According to research conducted in 2019 by Minakova and colleagues, Melanotan II seemed to have restored autistic characteristics in a mouse model of autism derived from a maternal immune activation (MIA) mouse

But if youre keen to give it a go, be sure to source your injectable peptides through a properly vetted clinician rather than social media